Urokinase-type plasminogen activator receptor in IgA nephropathy
- PMID: 24648797
- PMCID: PMC3956984
- DOI: 10.3904/kjim.2014.29.2.166
Urokinase-type plasminogen activator receptor in IgA nephropathy
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Comment on
-
Urokinase, urokinase receptor, and plasminogen activator inhibitor-1 expression on podocytes in immunoglobulin A glomerulonephritis.Korean J Intern Med. 2014 Mar;29(2):176-82. doi: 10.3904/kjim.2014.29.2.176. Epub 2014 Feb 27. Korean J Intern Med. 2014. PMID: 24648800 Free PMC article.
References
-
- Lee H, Kim DK, Oh KH, et al. Mortality and renal outcome of primary glomerulonephritis in Korea: observation in 1,943 biopsied cases. Am J Nephrol. 2013;37:74–83. - PubMed
-
- Lemley KV, Lafayette RA, Safai M, et al. Podocytopenia and disease severity in IgA nephropathy. Kidney Int. 2002;61:1475–1485. - PubMed
-
- Hill GS, Karoui KE, Karras A, et al. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. I. Immunohistochemical studies. Kidney Int. 2011;79:635–642. - PubMed
-
- El Karoui K, Hill GS, Karras A, et al. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies. Kidney Int. 2011;79:643–654. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources